|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/404 | (2006.01) |
| A61K 31/404 | (2013.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) |
| (11) | Patento numeris | 3908276 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20703633.6 |
| Europos patento paraiškos padavimo data | 2020-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-11-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-06-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/012783 |
| Data | 2020-01-08 |
| (87) | Numeris | WO 2020/146529 |
| Data | 2020-07-16 |
| (30) | Numeris | Data | Šalis |
| 201962789937 P | 2019-01-08 | US |
| (72) |
NAIK, Snehal , US
|
| (73) |
Arena Pharmaceuticals, Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR |
| METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR |